Description
Bellast Dermal filler Hyaluronic acid with lidocaine 1ml (Ultra L/Ultra Plus/ Ultra Soft – L) is a dermal filler from Bellast, listed for registered Australian clinics in our Dermal Filler range. Pack: 1ml (Ultra L/Ultra Plus/ Ultra Soft – L. Priced in AUD (A$45.00). Sydney dispatch, nationwide. Not a public treatment clinic.
About Bellast Dermal filler Hyaluronic acid with lidocaine 1ml (Ultra L/Ultra Plus/ Ultra Soft – L)
Bellast seires contains cross linked hyalouonic acid as an active ingredient. each product is designed to rejuvenate by filling wrinkles and folds, improve facial contour,create volume or have glowing complexion.you can choose the product depending on where you want to treat.
Bellast is a new generation plastic multi-reticulated gel based on double polymerization hyaluronic acid molecules. Bellast is a sterile, pyrogen-free, monophasic, biocompatible gel based on non-animal hyaluronic acid isolated on the basis of biosynthesis.
BELLAST Soft-L Composition:
HA – 18 mg/mL
Lidocaine 3mg/mL
BELLAST L Composition:
HA – 20 mg/mL
Lidocaine 3mg/mL
BELLAST Plus Composition:
HA – 24 mg/mL
Lidocaine 3mg/mL
BELLAST Package:
| BELLAST Soft-L
1 syringe (1.0 ml) 2 needles 30 G |
Wrinkles of nasolabial line, periorbital wrinkle, nose-perioral fold, dark circles, scowl lines, marionette lines and lip volume. |
| BELLAST L
1 syringe (1.0 ml) 2 needles 27G |
Wrinkles of nasolabial line. forehead, nasolabial fold, hollow cheeks, tip of the nose, nose augmentation, chin augmentation, scowl lines, marionette lines, lip volume. |
| BELLAST Plus
1 syringe (1.0 ml) 2 needles 27G |
Nasolabial folds, bridge of nose, chin, cheekbones |
Features of Bellast Fillers:
- Hypoallergenic, non-toxic.
- Made with high quality ingredients at the Shiseido Kakegawa factory in Japan.
- Increased viscosity.
- Thanks to the technology of increased concentration of crosslinked HA, the product has an increased viscosity, which prevents its penetration deep into the skin after application.
- Thanks to the excellent 3D structure, the effect of the drug will be longer.
- The product has been tested and is safe to use.
Buy 1-2 any brand fillers and get 5ea soothing masks Regeness
Buy 3 or more any brand fillers and get 10 ea soothing masks Regeness
Soothing masks Regeness contain 6 types of complex hyaluronic acid, which gives several effects such as skin protection, increasing moisture retention, calming down trouble skin and increasing elasticity.
Bellast Dermal filler Hyaluronic acid with lidocaine 1ml (Ultra L/Ultra Plus/ Ultra Soft – L) — key details for ordering
- Product: Bellast Dermal filler Hyaluronic acid with lidocaine 1ml (Ultra L/Ultra Plus/ Ultra Soft – L)
- Brand: Bellast
- Category: Dermal Filler
- Pack format: 1ml (Ultra L/Ultra Plus/ Ultra Soft – L
- Price: A$45.00 AUD, including GST where applicable
- Dispatch: Sydney, Australia-wide
Using Bellast Dermal filler Hyaluronic acid with lidocaine 1ml (Ultra L/Ultra Plus/ Ultra Soft – L) in clinic practice
Check the gel thickness, lidocaine content and syringe count on this page against your usual protocol before ordering. Store unopened boxes as the manufacturer directs, do not use after the expiry printed on the pack, and work from the manufacturer instructions and your own training for injection depth and technique.
Ordering Bellast Dermal filler Hyaluronic acid with lidocaine 1ml (Ultra L/Ultra Plus/ Ultra Soft – L) and related products
Compare Bellast Dermal filler Hyaluronic acid with lidocaine 1ml (Ultra L/Ultra Plus/ Ultra Soft – L) with Crystal Lite/Deep/Ultra filler, Avalon Fine/Fine Plus/Vital/Vital Plus/Grand Plus/Ultra Plus filler (1box/1 syringe x 1 ml + 2 needles), Liporase Fillers dissolver filler dissolver, or browse the full Dermal Filler catalogue. Clinics ordering in volume can use our wholesale enquiry program (AUD $5,000 minimum). See also the clinic FAQ and delivery information. Active-ingredient background for Bellast Dermal filler Hyaluronic acid with lidocaine 1ml (Ultra L/Ultra Plus/ Ultra Soft – L) is covered in the reference article on Hyaluronic acid, and Australian practitioners should confirm regulatory positionings with the TGA before use.
